Skip to main content
Immunology logoLink to Immunology
. 2009 Sep;128(1 Pt 2):e353–e365. doi: 10.1111/j.1365-2567.2008.02976.x

Peripheral blood CD27+ IgG+ B cells rapidly proliferate and differentiate into immunoglobulin-secreting cells after exposure to low CD154 interaction

Jessie F Fecteau 1,2, Annie Roy 1, Sonia Néron 1,2
PMCID: PMC2753896  PMID: 19016905

Abstract

In vitro CD40 stimulation of human B cells isolated from lymphoid organs is dominated by memory B cells undergoing faster proliferation and higher differentiation than naive B cells. In contrast, we previously reported that blood memory B cells mainly differentiate into immunoglobulin-secreting cells in response to CD40 stimulation. However, variations in CD40–CD154 interaction are now recognized to influence B-cell fate. In this study, we have compared the in vitro response of blood CD27 and CD27 IgG to CD27+ and CD27+ IgG+ B cells following low-density exposure to CD154 in the presence of a mixture of interleukin-2 (IL-2), IL-4 and IL-10. The evolution of these cell populations was monitored during initiation and following long-term stimulation. Over a 5-day period, CD27+ B cells underwent differentiation into immunoglobulin-secreting cells more readily than CD27 cells, and CD27+ IgG+ B cells gave rise to a near homogeneous population of CD19+ CD27++ CD38+ IgGlo cells capable of high immunoglobulin G (IgG) secretion. During the same period, CD27 IgG B cells partially became CD19++ CD27 CD38 IgG++ cells but showed no IgG secretion. Long-term stimulation revealed that CD27+ IgG+ B cells retained a high expansion capacity and could maintain their momentum towards differentiation over naive B cells. In addition, long-term stimulation was driving CD27 IgG and total CD19+ B cells to evolve into similar CD27+ and CD27 subsets, suggesting naive homeostatic proliferation. Overall, these results tend to reconcile memory B cells from blood and lymphoid organs regarding their preferential differentiation capacity compared to naive cells, and further suggest that circulating memory IgG+ cells may be intrinsically prone to rapid activation upon appropriate stimulation.

Keywords: CD40–CD154, IgG, memory B cells

Introduction

In humans, naive and memory B cells constitute the pool of mature B cells found in blood and in secondary lymphoid organs, such as tonsils, lymph nodes, Peyer’s patches and spleen. From the bloodstream, B cells migrate to lymphoid organs and screen for antigens against which they will mount effective primary and secondary immune responses.

In blood, naive and memory B cells can be distinguished by their differential expression of CD27,13 a membrane protein belonging to the tumour necrosis factor receptor family,4 CD27 expression is associated with the presence of somatic mutations in immunoglobulin variable genes generated in germinal centres.1,2 CD27 is routinely used to distinguish CD27 naive and CD27+ memory B cells, representing 60% and 40% of blood B cells, respectively.2,5 However, small immunoglobulin A-positive (IgA+) and IgG+ memory B-cell subsets lacking CD27 expression are now believed to be part of the memory B-cell population.69 In tonsils, germinal centre B cells become CD27+ without necessarily entering the memory compartment.1012

Several studies focusing on human splenic B cells have highlighted the distinct behaviour of CD27+ memory and CD27 naive B cells following a T-cell-dependent stimulation through CD40–CD154 interaction in the presence of various combinations of interleukin-2 (IL-2), IL-4 and IL-10.1316 The competitive advantage of memory B cells over naive cells towards proliferation and immunoglobulin secretion is related to the capacity of IgM+ and IgG/IgA+ memory B cells to enter active cell cycling.14,17 Furthermore, splenic memory B cells are committed to differentiate into CD27+ immunoglobulin-secreting cells more readily than naive cells,13,15 whereas naive B cells require in vitro isotype switching before gaining the capacity for IgG secretion.16 All these observations underscore the involvement of CD40–CD154 interaction taking place in vivo between antigen-activated B and T cells, as it promotes proliferation, isotype switching, generation of memory B cells and immunoglobulin production.1820

In contrast with these findings, we previously observed that a high level of CD154 interaction drives blood memory B cells into differentiation, whereas only naive cells rapidly proliferate and differentiate in response to the same stimulus.21 However, we also reported that variations in CD40–CD154 signal intensity influence the proliferation and differentiation of human peripheral blood B cells22 and a recent study using a human B-cell line stimulated with variable levels of CD154 revealed differential capacities to engage alternative nuclear factor-κB pathways.23 Overall, these studies suggest that the quantity and quality of CD154 lead to distinct functional B-cell responses (reviewed in refs 24, 25) and could reflect differential effects on naive and memory B-cell proliferation and differentiation. We therefore investigated whether the in vitro response of blood memory B cells differed from that previously reported21 when using a lower level of CD154 signal intensity in the presence of IL-2, IL-4 and IL-10. As performed elsewhere for splenic B cells,1316 naive and memory B cells were isolated according to CD27 expression and submitted to conditions of low CD40 stimulation supplemented with a mix of IL-2, IL-4 and IL-1022 for short-term (5 days) and long-term (14 days) culture periods. Furthermore, sorted CD19+ CD27 IgG naive B cells were directly compared with CD19+ CD27+ IgG+ memory B cells. Our results showed that CD40-activated blood CD27+ B cells more readily entered cell cycling during the first days of stimulation and showed higher differentiation into IgM- and IgG-secreting cells than CD27 cells. After long-term activation, both CD27+ memory and CD27 naive B cells expanded to comparable degrees but memory B cells showed a higher differentiation phenotype. In addition, CD27+ IgG+ cells showed the highest differentiation potential and were the fastest at entering the cell cycle and maintaining their momentum over naive B cells during long-term activation. These results showed that peripheral blood memory B cells proliferate and differentiate more readily than naive B cells following a low level of CD154 signal intensity.

Materials and methods

Peripheral blood B-cell isolation and cell sorting

This study has been reviewed and approved by the Héma-Québec Ethics Committee. Blood samples or leucoreduction filters from blood-collecting devices were obtained from healthy individuals after obtaining informed consent. B cells were isolated from peripheral blood mononuclear cells as previously described,21,26 using the StemSep™ CD19 cocktail (Stem Cell Technologies, Vancouver, Canada). B-cell purity, as determined by flow cytometry, was higher than 95% in all experiments reported herein. Cell sorting of CD19+ B cells according to CD27 and IgG expression was performed using an Epics Coulter or an Epics Elite ESP (Beckman Coulter, Burlington, Canada), after staining with phycoerythrin (PE)-conjugated anti-CD27 and fluorescein isothiocyanate (FITC)-conjugated anti-IgG (the source of these conjugates is given below). All subsets were more than 93% pure and used immediately after sorting.

Human B-cell culture and exposure to defined culture conditions

Purified B cells were seeded at 0·75 × 105 to 1·5 × 105 cells/ml in Primaria plates (BD Biosciences, Mississauga, Canada) in the presence of γ-irradiated (75 Gy; 7500 rad) L4.5 cells expressing CD154.27 A constant ratio of 25 B cells per L4.5 cell, which corresponds to about 1000 CD154 molecules per B cell as reported previously,22 was used in all assays. B cells were cultured in Iscove’s modified Dulbecco’s medium supplemented with 10% heat inactivated Ultra Low IgG fetal bovine serum (Gibco/BRL, Burlington, ON, Canada), 5·5 μg/ml transferrin, 6·7 mg/ml sodium selenite, antibiotics (all from Invitrogen, Burlington, Canada), 50 U/ml IL-2, 25 μg/ml IL-10 (PeproTech Inc., Rocky Hill, NJ) and 100 U/ml IL-4 (R&D Systems, Minneapolis, MN). If necessary, L4.5 cells were renewed every 4–5 days, and half of the culture medium was replaced every 2–3 days. Cell counts and viability were evaluated in triplicates using trypan blue dye exclusion. Generation time (tgen) was calculated within the initiation phase of the growth curve according to the formula:

graphic file with name imm0128-e353-mu1.jpg

Flow cytometry and CFSE labelling

Peridinin chlorophyll protein-cyanin 5.5 (PerCP-Cy5.5)-anti-CD19, PE-anti-CD27, FITC-anti-IgG, allophycocyanin (APC)-anti-CD27, APC-anti-CD38 and PerCP-Cy5.5-, PE-, FITC- and APC-conjugated isotype controls were used in triple or quadruple staining procedures. All antibodies were mouse monoclonal IgG1 obtained from BD Pharmingen (Mississauga, Canada). Stainings and analyses were performed as described previously,21,22 using a BD FACScalibur™ flow cytometer and the BD cellquest™ Pro software (BD Biosciences). Data were subsequently analysed using fcsexpress software (De Novo Software, Thornhill, Canada). Purified CD19+ cells were also stained with 5 μm carboxyfluorescein succinimidyl ester (CFSE; Molecular Probes, Eugene, OR) before being stimulated as described above. CFSE cell content was analysed on day 5 as a function of CD27 expression using APC-anti-CD27 and data were subsequently analysed using modfit lt software (version 3.0; Verity Software House, Topsham, ME) to determine the percentage of subsets within each daughter generation.

Cell proliferation assays

Cellular proliferation was monitored using 5-bromo-2′-deoxy-uridine (BrdU) incorporation from day 4 to 5 following the manufacturer’s instructions (Roche Molecular Biochemicals, Indianapolis, IN). Briefly, CD19+ blood B cells and sorted CD19+ CD27, CD19+ CD27+, CD19+ CD27 IgG and CD19+ CD27+ IgG+ were seeded in triplicate at 7·5 × 104 cells/ml in flat-bottomed 96-well plates in the presence of 0·3 × 104γ-irradiated L4.5 cells/ml and IL-2, IL-4 and IL-10 as described above. The γ-irradiated L4.5 cells did not incorporate BrdU.

Quantification of IgG and IgM secretion

Concentrations of IgG and IgM were determined in supernatants by a standard enzyme-linked immunosorbent assay.21 For the determination of IgG and IgM secretion rate in long-term assays, cells were harvested, extensively washed with phosphate-buffered saline and seeded at 1 × 106 cells/ml in Iscove’s modified Dulbecco’s medium alone for 24 hr.

Reverse transcription–polymerase chain reaction (RT-PCR) amplification of human IgG transcript VH regions, subcloning and sequencing

Total RNA from resting blood B cells, and from CD19+, CD19+ CD27 and CD19+ CD27+ B cells cultured for 14 days in the presence of L4.5 cells and IL-2, IL-4 and IL-10, was isolated using TRIzol Reagent (Invitrogen).6 A strategy broadening the repertoire of amplified transcripts was adopted to overcome the previously observed bias for the large VH3 family.21 Briefly, IgG messenger RNA was amplified with primers specific to VH1, VH2, VH3, VH4, VH5 and VH6 families (5′) (all described in ref. 28) paired with a Cγ-specific primer (3′) (5′-AAGTAGTCCTTGACC-3′). Using the Titan™ One Tube RT-PCR System (Roche Diagnostics Canada, Laval, Canada) and the following program (30 min reverse transcription at 50° followed by a 35-cycle PCR of 94° for 30 seconds, 45° for 40 seconds and 72° for 60 seconds, with a final elongation step at 72° for 10 min), 500–650 nucleotide amplicons were generated. All IgG VH amplicons were resolved on 1% agarose gel electrophoresis, purified using the QIAquick Gel Extraction Kit (Qiagen, Mississauga, Canada), pooled and subcloned into the pDRIVE vector from the Qiagen PCR Cloning kit. Plasmid DNA was purified and inserts were sequenced by automated fluorescent DNA sequencing (ABI 373; Perkin-Elmer Applied Biosystems, Foster City, CA).6 The error rate of the Taq DNA polymerase mix was 0·34%, representing one mutation every 294 nucleotides.21

Mutational analysis of IgG VH genes

Mutational analysis of VH transcripts was performed using the international ImMunoGeneTics database (IMGT), which is available on the internet (http://imgt.cines.fr).29 The distribution and number of mutations were determined after the alignment of each sequenced transcript with the germline gene presenting the highest homology from the FR1 to FR3 regions. The proportions of replacement (R) mutations in framework regions (FR) and complementarity determining regions (CDR), comprising FR1 (26 amino acids), FR2 (17 amino acids) and FR3 (39 amino acids) and CDR1 (12 amino acids) and CDR2 (10 amino acids), respectively, were calculated and used as an index of antigenic selection.

Results

Differential responses of CD27+ and CD27 B cells to low levels of CD154 interaction

The in vitro evolution of peripheral blood naive and memory cells was compared using sorted CD27 and CD27+ B cells (≥ 95% pure) stimulated for 14 days in conditions of low exposure to CD154 in the presence of IL-2, IL-4 and IL-10 (Fig. 1). The response of total CD19+ cells, used as control for the low CD154 stimulus, was consistent with our previous observations.22 During the first 5 days, the viability of all cell populations was higher than 90% (data not shown). Both CD27+ and CD27 cells showed comparable expansions (approximately fivefold; Fig. 1a). This initial expansion phase was also characterized by IgG and IgM secretion, which was at least fourfold higher in CD27+ compared with CD27 B cells (Fig. 1b). Similar levels of IgM and IgG secretion were observed within CD27 cells; such a rapid IgG secretion within the CD27 population suggested that the minor CD27 IgG+ memory B-cell subset6 was rapidly induced to differentiate into IgG-secreting cells, as observed for CD27+ cells. Following long-term stimulation, the expansions of CD27 and CD27+ B cells were comparable, albeit about twofold lower than that of CD19+ cells (Fig. 1a). On day 14, the viability of all populations had decreased but was still above 70% (data not shown). For all populations, IgM secretion was overwhelmed by that of IgG by up to eightfold (Fig. 1c). Noticeably, differentiation of CD27+ memory B cells was characterized by a high rate of IgG secretion, approximately threefold higher than CD27 and CD19+ cells. Overall, these results showed that blood CD27+ B cells are more competent than CD27 cells to differentiate into immunoglobulin-secreting cells following low CD40 interaction.

Figure 1.

Figure 1

CD27+ B cells are more efficient than CD27 cells at immunoglobulin secretion. Total CD19+ and sorted CD19+ CD27 and CD19+ CD27+ peripheral blood B cells were stimulated with CD154 in the presence of interleukin-2 (IL-2), IL-4 and IL-10. (a) Expansion was determined on days 5, 9 and 14 and (b) immunoglobulin G (IgG) and IgM concentrations were measured at the end of the 5-day culture period. (c) IgG and IgM secretion rates after 14 days of culture. (d) CFSE labelling and CD27 staining were used to track cell division of CD27+ (proliferation index 7·9) and CD27 (proliferation index 9·2) populations within total CD19+ cells over a 5-day-period. These results are representative of three independent experiments, all performed with different blood samples. Each experiment was performed in triplicate. Error bars can be smaller than symbols and represent variations among triplicates in this experiment.

The proliferative advantage of splenic memory B cells over naive cells was reported in studies using incorporation of [H3]thymidine17 as well as CFSE labelling.14 The relative proliferation of blood memory and naive cells grown in conditions of low CD154 interaction was evaluated using CFSE labelling to track cell divisions as a function of CD27 expression (Fig. 1d). In agreement with the similar expansions of CD27+ and CD27 cells observed on day 5, CFSE labelling indicated that CD27 cells had a slight advantage over CD27+ cells, given that on day 5 about 95% of CD27 cells had already undergone four or more generations compared to about 86% for CD27+ cells (Fig. 1d). In fact, a small fraction (approximately 15%) of CD27+ cells was lagging, while another (approximately 2%) was already at its sixth generation, suggesting heterogeneity within the CD27+ cell population itself. Differentiating cells are expected to be delayed in their cell cycle progression, so this small CD27+ population could represent differentiated cells sustaining a very high immunoglobulin secretion rate, whereas most of the cells could still be characterized by a high proliferation rate.

Heterogeneous evolution of blood CD27+ and CD27 B cells

Based on the above observations, the evolution of CD27 and CD27+ B cells was monitored using CD19, CD27 and IgG staining after exposure to low levels of CD154 stimulation for 5 and 14 days (Fig. 2). Total CD19+ cells were used as the control in parallel. After 5 days, a large proportion of CD27+ B cells maintained expression of this surface marker; within this population, the average CD27 expression was increased (Fig. 2a), and the proportion of surface IgG+ cells was comparable to that found on day 0 (Fig. 2b). At the same time, the phenotypic pattern of CD27+ cells became more heterogeneous, with populations that were CD19lo IgG (approximately 10%), CD19+ IgG (approximately 50%) and CD19+ IgG+ (35%). These subsets could have distinct secretion and proliferation capacities responsible for the results described above (Fig. 1). After 5 days in similar culture conditions, fractions of cells that were initially CD27 acquired expression of CD27 (24%) and surface IgG (14%). After 14 days, a majority of sorted CD27+ cells (62%) were differentiated into CD27++ cells that were also mostly negative for surface IgG (Fig. 2c). When CD19+ cells were cultured in similar conditions, the phenotypic analyses revealed that both CD27+ and CD27 cells could still be detected after 5 days, but the proportion of CD27+ cells was substantially reduced after 14 days. In fact, long-term stimulation of CD19+ and sorted CD27 cells led to very similar phenotypic patterns regarding CD27 (27% for CD19+, and 25% for CD19+CD27), IgG (63% for CD19+, and 69% for CD19+CD27) and IgG+ CD27 (43% for CD19+, and 49% for CD19+ CD27) expression.

Figure 2.

Figure 2

Heterogeneous populations emerge from blood CD27+ and CD27 B cells. CD19, CD27 and surface immunoglobulin G (IgG) expression was evaluated by flow cytometry (> 5000 events) of cultures started with total CD19+ and sorted CD19+ CD27 (CD27) and CD19+ CD27+ (CD27+) B cells. (a) CD19 and CD27 expression and (b) CD19 and surface IgG expression were measured on days 0, 5 and 14. (c) Phenotypic CD27 and IgG expression on day 14 are shown. These results are representative of two independent experiments and similar results were observed on day 5 in a supplemental short-term assay.

To verify whether the recently described CD27 IgG+ memory cell population6 was still present within sorted CD27 cells following long-term stimulation, or else had completely differentiated into IgG-secreting cells during the first 5 days of culture, we performed mutational analysis of IgG transcripts from resting blood CD19+ B cells and CD40-activated, sorted CD19+, CD27 and CD27+ cells following 14 days of stimulation (Fig. 3). To discriminate mutated from unmutated immunoglobulin genes30 and to exclude in vitro-generated mutations,21,31 only transcripts with four or more mutated amino acids were considered as hypermutated. The analysis of IgG transcripts amplified from resting blood B cells, resulting from in vivo antigenic selection, indicated for each clone a higher frequency of R mutations in CDRs than in FRs (Fig. 3a). A majority (70%) of sequenced IgG transcripts amplified from sorted CD27+ cells carried 6–30 mutated amino acids, with a higher proportion of R mutations in CDRs than in FRs (Fig. 3d). In contrast, total CD19+ and CD27 cells had 17% and 20%, respectively, of mutated IgG transcripts, but only 10% and 13%, respectively, presented mutations consistent with in vivo antigenic selection (Fig. 3b,c). These observations seemed consistent with the expansion of the minor IgG+ memory cell subset within the CD27 population after long-term stimulation. The contribution of CD27+ IgG+ cells in long-term expanded CD19+ cells appeared rather modest because very few transcripts had mutations consistent with in vivo antigenic selection after 14 days of culture, even though CD27+ IgG+ cells outnumbered CD27 IgG+ cells at the start of the culture. Such similarities between the resulting mutated IgG transcripts suggest that low-abundance CD27 IgG+ cells were maintained during long-term expansion of CD40-activated CD19+ cells and CD27 cells. Whether these long-term memory IgG+ cells emerged from the initial CD27+ IgG+ population or the minor CD27 IgG+ memory cells remains to be investigated. Additionally, molecular as well as phenotypic similarities between total CD19+ and CD27 populations suggest that these distinct populations tend to converge towards similar cell phenotypes following long-term stimulation. Overall, these results revealed heterogeneous subset evolution within sorted CD27 and CD27+ populations.

Figure 3.

Figure 3

CD27 IgG+ cells persist within the CD27 cells following long-term stimulation. (a) Nine IgG transcripts from resting blood CD19+ B cells were amplified, sequenced and analysed for the presence of somatic mutations, in parallel with transcripts from (b) unsorted CD19+ B cells, (c) sorted CD27 B cells and (d) sorted CD27+ B cells stimulated for 14 days with CD154, interleukin-2 (IL-2), IL-4 and IL-10. All characterized IgG transcripts from two donors (1A or 1B) are presented; the number of clones, their origin, and the number of mutated amino acids are indicated. The distribution of R (Replacement: Inline graphic) and S (Silent; Inline graphic) mutations is shown only when four or more mutated amino acids were observed. The proportions (%) of R mutations found in FR1, FR2 and FR3 (framework regions; cumulative length: 82 amino acids), and in CDR1 and CDR2 (complementarity determining regions; cumulative length: 22 amino acids) are shown for each sequence. *Clones considered to have arisen independently from antigen selection.

Blood CD27+ IgG+ memory B cells are highly efficient at expansion and immunoglobulin secretion

The above-described CD27+ B-cell population comprises CD27+ IgM+ IgD+ cells, which are associated with the splenic marginal zone, arising independently of germinal centres and considered to be responsible for T-cell-independent immune responses.3234 Indeed, the relationship of this B-cell subset with the memory pool is still under debate.35 On the other hand, the above-described naive CD27 cells include a subset of memory cells of phenotype CD27 IgG+/IgA+.7,9 Even though most studies regarding memory and naive B cells rely upon sorting according to CD27 expression,1316 we decided to refine our investigations to specifically target CD27+ IgG+ memory B cells. Therefore, blood B cells (CD19+) were sorted into CD19+ CD27 IgG and CD19+ CD27+ IgG+ cells with purities ranging from 93 to 100% (Fig. 4; day 0). The two B-cell subsets were stimulated in conditions of low levels of CD154 interaction and their proliferation and differentiation were monitored after 5 and 13 days of culture (Table 1). During the first 5 days, the average tgen of CD27+ IgG+ cells was 33 hr, compared to 72 hr for CD27 cells, and BrdU incorporation revealed an increased DNA synthesis for CD27+ IgG+ cells. In agreement with these observations, expansion of CD27+ IgG+ cells on day 5 was approximately fourfold higher than that of CD27 IgG and CD19+ cells (data not shown). During this same time-frame, IgG concentration from secreting CD27+ IgG+ cells reached very high levels (> 20 μg/ml). Meanwhile, CD27 IgG naive cells were secreting negligible amounts of IgG, whereas IgM concentration (460 ng/ml, data not shown) was similar to that of sorted CD27 cells (Fig. 1), suggesting that in vitro isotype switching to IgG occurred at a later time-point.

Figure 4.

Figure 4

CD27+ IgG+ cells give rise to CD38+ IgG+ and CD38 IgGlo cells. Total CD19+ and sorted CD19+ CD27 IgG and CD19+ CD27+ IgG+ B cells, stimulated as described in Table 1, were analysed after 5 days in culture for CD19, CD27 and immunoglobulin G (IgG) expression by flow cytometry (> 500 events). Cell purity before stimulation is shown (d = 0). The proportion of IgG+ cells as a function of CD27 expression is presented for each subset. These results are representative of two independent experiments.

Table 1.

Peripheral blood CD27+ IgG+ B cells show the highest proliferation and immunoglobulin G secretion rate

Short term2
Long term3
Phenotype1 tgen (hr) BrdU (OD 450 nm) IgG ng/ml Expansion (fold) IgG ng/106 cells/hr
CD19+ 61 ± 3 1·35 ± 0·06 1114 ± 100 151 ± 9 1519 ± 65
CD27 IgG 72 ± 5 1·34 ± 0·18 14 ± 1 46 ± 1 906 ± 68
CD27+ IgG+ 33 ± 2 1·84 ± 0·07 21548 ± 1044 300 ± 18 2126 ± 3

tgen, generation time; IgG, immunoglobulin G; BrdU, 5-bromo-2′-deoxy-uridine.

1

Total CD19+ and sorted CD19+ CD27 IgG and CD19+ CD27+IgG+ B cells were stimulated with CD154 in the presence of interleukin-2 (IL-2), IL-4 and IL-10. These results are representative of two independent experiments. SD represented variations among triplicate values obtained in this particular experiment.

2

tgen and total IgG accumulations were determined over the first 5 days, and BrdU incorporation was measured from day 4 to 5. Viability of all the cells remained > 93% (data not shown).

3

Expansion and IgG secretion were determined on day 13.

In contrast to the entire population of CD27+ cells described in Fig. 1, CD27+ IgG+ memory cells maintained a higher expansion than CD27 IgG B cells during long-term stimulation (Table 1). This preferential expansion was, however, mainly related to the momentum acquired during the initial phase of the culture (data not shown). Furthermore, in agreement with previous observations22 and the results of Table 1, IgG secretion on day 13 overwhelmed IgM secretion by 10-fold and 20-fold in CD27 IgG and CD19+ cells, respectively (data not shown). Overall, during short-term activation, the proliferation and differentiation of CD27+ IgG+ memory B cells were both higher than that of naive CD27 IgG cells. Moreover, CD27+ IgG+ cells were able to maintain their superiority over naive cells following long-term stimulation, as shown by their twofold higher IgG secretion rate on day 13, which further illustrates their commitment towards differentiation into immunoglobulin-secreting cells.

CD27+ IgG+ cells evolve towards CD38+ IgG+ and CD38 IgGlo cells

To investigate the short-term evolution of CD40-activated CD27 IgG and CD27+ IgG+ cells, the expression of CD19, CD27, CD38 and IgG was determined and compared to that of CD19+ peripheral blood B cells (Fig. 4). After 5 days of culture, about 90% of CD27+ IgG+ cells showed slightly increased CD27 expression, characterized by a mean fluorescence intensity (MFI) of 95 compared to 60 on day 0. In contrast, the proportion of IgG+ cells (Fig. 4; 55%), as well as the level of surface IgG expression had decreased, from an initial MFI of 190 to an average of 40. After short-term activation, CD27+ IgG+ cells could be subdivided into CD19+ CD27++ CD38 IgG+, and more differentiated CD19+ CD27++ CD38+ IgGlo cells associated with an elevated IgG secretion rate (Table 1). During the same 5-day period, only a small fraction of CD27 IgG B cells expressed high surface IgG (6%; MFI approximately 100). Additionally, most cells (> 80%), including those IgG+ cells, maintained a high expression of CD19+ (MFI approximately 200) but remained negative for CD27 and CD38. Of note, even though IgG+ cells were readily detected within this cell population, IgG secretion was still negligible (Table 1). Similarly, CD27 IgG+ cells (approximately 6%) were present among CD40-activated CD19+ cells and can therefore be associated with cells differentiated in vitro and characterized by the CD19++ IgG++ CD27 CD38 phenotype. As described above (Fig. 2a), based on the phenotypes of B cells according to IgG, CD27 and CD38 expression, populations of both CD27 IgG and CD27+ IgG+ cells seemed to be concomitantly present within the total CD19+ cell population on day 5.

CD27+ IgG+ cells differentiate into CD19lo CD27++ CD38++ IgG cells following long-term stimulation

To further investigate the in vitro differentiation of the above-described B-cell populations, the phenotypes of CD40-activated CD27 IgG, CD27+ IgG+ and total CD19+ B cells were determined as above after 14 days of culture (Fig. 5). Such long-term activation of CD27+ IgG+ cells resulted in a fairly homogeneous phenotype characterized by high levels of CD27 (MFI approximately 300) and CD38 (MFI approximately 200), low levels of CD19 (MFI approximately 30) and loss of surface IgG. Of note, these cells showed intracellular IgG and were negative for surface IgM expression (data not shown) and their homogeneous phenotype CD19lo CD27++ CD38++ IgG is consistent with a high differentiation status towards plasma cells.3639

Figure 5.

Figure 5

Long-term stimulation drives CD27+ IgG+ cells into plasma cell differentiation. Unsorted blood B cells (CD19+) and sorted CD19+ CD27 IgG and CD19+ CD27+ IgG+ populations were stimulated with CD154, interleukin-2 (IL-2), IL-4 and IL-10 for 14 days and monitored for expression of CD19, CD27, CD38 and surface immunoglobulin G (IgG) by flow cytometry (> 10 000 events). All sorted populations were ≥ 94% pure. On day 0, the frequencies of CD27+, CD27, CD27+ IgG+, CD27 IgG+ and CD27 IgG cells within CD19+ cells were 21%, 79%, 6%, 4%, and 75%, respectively. The level of CD38 expression (mean fluorescence intensity) on resting B cells varied from 7 to 27. These results are representative of two independent experiments.

Consistent with the above results (Figs 2 and 3), CD27IgG and total CD19+ cells evolved similarly, giving rise to two major populations, CD19+ CD27 and CD19lo CD27+ cells, representing about 40% and 60% of total cells, respectively (Fig. 5). In both cases, the CD19+ CD27 subset showed low expression of CD38 (MFI approximately 20) and was divided between IgG+ and IgG cells (data not shown). A similar distribution between IgG+ and IgG cells was also observed for the CD19lo CD27+ cell subset, which was characterized by a high level of CD38 expression, with MFIs of approximately 100 (IgG+) and approximately 170 (IgG), respectively (data not shown). The unique phenotype acquired by long-term activated CD27+ IgG+ cells appeared almost absent from these two populations. Once more (day 14; Fig. 2), CD19+ and CD27 IgG populations led to similar phenotypes following long-term stimulation, suggesting again a tendency to reach a common equilibrium within these B-cell populations. In addition, these results also suggested that the memory CD27+ cells initially present within CD19+ cells were unable to expand significantly following long-term CD40 stimulation, such that most CD27+ cells detected at the end of the culture arose from a CD27 population.

Discussion

In this study, we showed that blood CD27+ IgG+ memory B cells have a preferential growth advantage over CD27 IgG naive B cells, as demonstrated by their enhanced capacity to rapidly enter into the active cell cycle and proliferate. Furthermore, CD27+ IgG+ cells rapidly differentiated into immunoglobulin-secreting cells during the initial phase of the culture and maintained this characteristic following long-term CD40 stimulation, reaching a fairly homogeneous CD19lo CD38++ CD27++ cell population resembling the plasma cell phenotype.13,40 Accordingly, such higher proliferation and IgG secretion of blood CD27+ IgG+ cells are in agreement with observations made for CD27+ splenic B cells using a cell-bound17 or soluble membrane1316 source of CD154 to activate CD40 in the presence or absence of cytokines. In vivo, higher and sustained expansion of CD27+ IgG+ memory cells following limited CD40 stimulation could be further enhanced by activation through the IgG cytoplasmic tail, which is able to sustain a division burst and B-cell survival during T-cell-dependent responses.41

Our findings underscore that enhanced activation of CD27+ IgG+ memory cells was observed in conditions of low levels of CD40 stimulation and in the presence of IL-2, IL-4 and IL-10, and these results are consistent with our previous observations.22 These observations also suggest that the proliferative advantage of naïve over memory B cells as observed before21 was related to the higher level of CD154 interaction (approximately 10-fold) in the presence of IL-4 or IL-10 alone. In vivo, memory B cells are believed to preferentially interact with memory T cells,42 which can indeed secrete these three cytokines simultaneously.43 Several studies in mice and humans indicate that T-cell activation induces surface expression of CD154, and that this expression is transient and highly regulated.4447 Both naive and memory T cells are induced to express high levels of surface CD154, but only within hours following cellular activation (reviewed in ref. 48). In humans, it has been reported that tonsil memory T cells, which have preformed CD154 molecules, can express low levels of CD154 on their cell membrane within 5–15 min after cellular activation.46 Low levels of CD154 expression have also been reported in subsets of human memory T cells47 as well as in naive CD4+ T cells in mouse models.49 In mice, memory T cells have lower and transient expression of CD15444 and can also have preformed CD154 molecules.45 Consequently, our results suggest that IgG+ memory B cells might be able to respond to a second antigenic challenge even when CD154 expression is limited on activated memory T cells found in the outer zone of germinal centres and margins of the T zone.46 This response to low levels of CD154 interaction might also be relevant in vivo to the highly motile germinal centre B cells, whose access to helper T cells in the light zone is very limited in time.50

In addition, the fact that short-term stimulation of sorted CD27 IgG cells led to an almost exclusive IgM secretion suggests that CD27 IgG+ memory cells within CD40-activated CD27 cells were probably responsible for most of the observed IgG secretion during the same period (Fig. 1b) and so have differentiation capacities similar to those of CD27+ IgG+ cells. In addition, the presence of about 13% IgG+ cells carrying mutated VH genes within sorted CD27 cells indicates that these CD27 IgG+ cells were proliferating and stably maintained following long-term activation, suggesting a strong renewal capacity for this subset. These observations support the notion that this small subset belongs to the memory B-cell compartment. Whether the IgA+ cells, representing about 2% of the CD27 populations7,9 and therefore also present within the CD27 IgG cells, could follow the same pathway as their IgG+ counterpart or influence the other populations remains to be investigated.

B-cell differentiation towards immunoglobulin-secreting cells is linked to an arrest in cell cycle progression.51,52 Therefore, differentiation and proliferation are opposite manifestations of B-cell maturation underlying divergent responses among CD27+ IgG+cells. It has also been suggested that following a second antigenic challenge, memory B cells divide into undifferentiated blasts to maintain the memory pool as well as antibody-secreting plasma cells.53 Indeed, results presented in this study showed that CD40-activated CD27+ IgG+ memory cells rapidly evolved into two main populations, namely CD19+ CD27++ CD38 IgG+ and CD19+ CD27++ CD38+ IgGlo cells, which can be respectively associated with cells in transition towards the memory pool13 and towards differentiation into plasma cells.40 Therefore, the high and sustained proliferation observed within activated CD27+ IgG+ cells could originate from highly proliferative CD19+ CD27++ CD38 IgG+ cells, while immunoglobulin secretion could be derived from more differentiated CD19+ CD27++ CD38+ IgGlo cells. However, at the end of the long-term stimulation, a trend favouring plasma cell differentiation could be observed, suggesting that continuous CD40 activation might have exhausted their regeneration capacity towards the memory cell pool.

The results of this study further indicate that long-term CD40 stimulation of sorted CD27 IgG and total CD19+ B cells generated similar phenotypic patterns, implying that CD27+ populations did not have a selective growth advantage over unsorted CD19+ cells. The negative impact of CD27 cells on CD27+ cell expansion could be mediated by homotypic interactions involving costimulatory molecules such as CD27 and CD70.54 In fact, long-term stimulation of CD19+ B cells leads to the emergence of both CD27+ as well as CD70+ cells (data not shown). The CD27–CD70 interaction induces reciprocal activation (reviewed in refs 54, 55); the binding of CD27 promotes differentiation of CD27+ cells56 while CD70+ cells are driven into the cell cycle.57 Therefore, CD27+ cells could enhance their differentiation when interacting with CD70+ cells emerging in response to CD40 activation, and in turn CD70+ cells could increase their proliferation. Such interactions could also allow CD27 IgG+ cells to reach higher expansion than CD27+ IgG+ cells within the CD19+ population, as long as these cells were not induced to express CD27. This hypothesis is currently under investigation.

Similar phenotypic patterns to sorted CD27 IgG and total CD19+ B cells also suggest a possible connection with homeostatic B-cell proliferation.58,59 Homeostasis is important in maintaining appropriate numbers of immune cells in the periphery and in lymphoid organs (reviewed in refs 60, 61). Homeostatic proliferation of naive B cells has been previously observed in response to a B-cell deficit in a mouse model.58,62 In humans, homeostatic proliferation of naive B cells (reviewed in refs 63, 64) has been highlighted within peripheral blood B cells by examining their replication history.59 In our study, enhanced proliferation in response to a B-cell deficit generated through cell sorting could be involved in long-term stimulation of CD27 IgG cells. On the other hand, the involvement of balanced proliferation within the entire CD19+ cell population could be related to intrinsic characteristics of naive B cells or induced following the progressive decline of those memory B cells initially present in the culture. Whether CD27–CD70 interactions drive both CD27 IgG and CD19+ cells to reach the observed final subsets deserves further investigation.

In light of these observations, it could be speculated that in the presence of memory T cells expressing low levels of CD154, blood CD27+ IgG+ memory B cells entering lymphoid organs would have a selective advantage compared to CD27 IgG naive B cells for proliferation, differentiation, and immunoglobulin secretion. Taken together, our findings also suggest that memory B cells from blood and lymphoid organs have comparable superiorities over naive B cells in terms of proliferation and differentiation. Finally, our in vitro observations regarding the long-term equilibrium reached by naive and CD19+ B cells could provide supplemental clues regarding communications between naive and memory B cells and homeostatic proliferation.

Acknowledgments

The authors are thankful to all the volunteers who participated in this study, and to Claudine Côté for the coordination of blood sample collection, Renée Bazin for critical review of the manuscript and Jean-François Leblanc for manuscript editing and revision. The authors also thank André Darveau for constructive discussions. J.F.F. was supported by a PhD fellowship from the Fonds Québécois de la Recherche sur la Nature et les Technologies and Héma-Québec.

References

  • 1.Agematsu K, Hokibara S, Nagumo H, Komiyama A. CD27: a memory B-cell marker. Immunol Today. 2000;21:204–6. doi: 10.1016/s0167-5699(00)01605-4. [DOI] [PubMed] [Google Scholar]
  • 2.Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med. 1998;188:1679–89. doi: 10.1084/jem.188.9.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Tangye SG, Liu YJ, Aversa G, Phillips JH, de Vries JE. Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med. 1998;188:1691–703. doi: 10.1084/jem.188.9.1691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Goodwin RG, Alderson MR, Smith CA, et al. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor. Cell. 1993;73:447–56. doi: 10.1016/0092-8674(93)90133-b. [DOI] [PubMed] [Google Scholar]
  • 5.Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341:1520–9. doi: 10.1056/NEJM199911113412007. [DOI] [PubMed] [Google Scholar]
  • 6.Fecteau JF, Côté G, Néron S. A new memory CD27−IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol. 2006;177:3728–36. doi: 10.4049/jimmunol.177.6.3728. [DOI] [PubMed] [Google Scholar]
  • 7.Ma CS, Pittaluga S, Avery DT, Hare NJ, Maric I, Klion AD, Nichols KE, Tangye SG. Selective generation of functional somatically mutated IgM(+)CD27(+), but not Ig isotype-switched, memory B cells in X-linked lymphoproliferative disease. J Clin Invest. 2006;116:322–33. doi: 10.1172/JCI25720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wei C, Anolik J, Cappione A, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol. 2007;178:6624–33. doi: 10.4049/jimmunol.178.10.6624. [DOI] [PubMed] [Google Scholar]
  • 9.Wirths S, Lanzavecchia A. ABCB1 transporter discriminates human resting naive B cells from cycling transitional and memory B cells. Eur J Immunol. 2005;35:3433–41. doi: 10.1002/eji.200535364. [DOI] [PubMed] [Google Scholar]
  • 10.Bohnhorst JO, Thoen JE, Natvig JB, Thompson KM. Significantly depressed percentage of CD27+(memory) B cells among peripheral blood B cells in patients with primary Sjogren’s syndrome. Scand J Immunol. 2001;54:421–7. doi: 10.1046/j.1365-3083.2001.00989.x. [DOI] [PubMed] [Google Scholar]
  • 11.Brighenti A, Andrulis M, Geissinger E, Roth S, Muller-Hermelink HK, Rudiger T. Extrafollicular proliferation of B cells in the absence of follicular hyperplasia: a distinct reaction pattern in lymph nodes correlated with primary or recall type responses. Histopathology. 2005;47:90–100. doi: 10.1111/j.1365-2559.2005.02173.x. [DOI] [PubMed] [Google Scholar]
  • 12.Ehrhardt GR, Hsu JT, Gartland L, Leu CM, Zhang S, Davis RS, Cooper MD. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med. 2005;202:783–91. doi: 10.1084/jem.20050879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Avery DT, Ellyard JI, Mackay F, Corcoran LM, Hodgkin PD, Tangye SG. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J Immunol. 2005;174:4034–42. doi: 10.4049/jimmunol.174.7.4034. [DOI] [PubMed] [Google Scholar]
  • 14.Tangye SG, Avery DT, Deenick EK, Hodgkin PD. Intrinsic differences in the proliferation of naïve and memory human B cells as a mechanism for enhanced secondary immune responses. J Immunol. 2003;170:686–94. doi: 10.4049/jimmunol.170.2.686. [DOI] [PubMed] [Google Scholar]
  • 15.Tangye SG, Avery DT, Hodgkin PD. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J Immunol. 2003;170:261–9. doi: 10.4049/jimmunol.170.1.261. [DOI] [PubMed] [Google Scholar]
  • 16.Tangye SG, Ferguson A, Avery DT, Ma CS, Hodgkin PD. Isotype switching by human B cells is division-associated and regulated by cytokines. J Immunol. 2002;169:4298–306. doi: 10.4049/jimmunol.169.8.4298. [DOI] [PubMed] [Google Scholar]
  • 17.Gagro A, Toellner KM, Grafton G, et al. Naive and memory B cells respond differentially to T-dependent signaling but display an equal potential for differentiation toward the centroblast-restricted CD77/globotriaosylceramide phenotype. Eur J Immunol. 2003;33:1889–98. doi: 10.1002/eji.200323357. [DOI] [PubMed] [Google Scholar]
  • 18.Bernard A, Coitot S, Bremont A, Bernard G. T and B cell cooperation: a dance of life and death. Transplantation. 2005;79:S8–11. doi: 10.1097/01.tp.0000153290.75695.31. [DOI] [PubMed] [Google Scholar]
  • 19.Bishop GA, Hostager BS. The CD40-CD154 interaction in B cell-T cell liaisons. Cytokine Growth Factor Rev. 2003;14:297–309. doi: 10.1016/s1359-6101(03)00024-8. [DOI] [PubMed] [Google Scholar]
  • 20.Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol. 1998;16:111–35. doi: 10.1146/annurev.immunol.16.1.111. [DOI] [PubMed] [Google Scholar]
  • 21.Fecteau JF, Néron S. CD40 stimulation of human peripheral B lymphocytes: distinct response from naïve and memory cells. J Immunol. 2003;171:4621–9. doi: 10.4049/jimmunol.171.9.4621. [DOI] [PubMed] [Google Scholar]
  • 22.Néron S, Racine C, Roy A, Guérin M. Differential responses of human B-lymphocyte subpopulations to graded levels of CD40-CD154 interaction. Immunology. 2005;116:454–63. doi: 10.1111/j.1365-2567.2005.02244.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Stewart R, Wei WB, Challa A, et al. CD154 tone sets the signaling pathways and transcriptome generated in model CD40-Pluricompetent L3055 Burkitt’s lymphoma cells. J Immunol. 2007;179:2705–12. doi: 10.4049/jimmunol.179.5.2705. [DOI] [PubMed] [Google Scholar]
  • 24.Fanslow WC, Srinivasan S, Paxton R, Gibson MG, Spriggs MK, Armitage RJ. Structural characteristics of CD40 ligand that determine biological function. Semin Immunol. 1994;6:267–78. doi: 10.1006/smim.1994.1035. [DOI] [PubMed] [Google Scholar]
  • 25.Gordon J, Pound JD. Fortifying B cells with CD154: an engaging tale of many hues. Immunology. 2000;100:269–80. doi: 10.1046/j.1365-2567.2000.00074.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Néron S, Thibault L, Dussault N, Cote G, Ducas E, Pineault N, Roy A. Characterization of mononuclear cells remaining in the leukoreduction system chambers of apheresis instruments after routine platelet collection: a new source of viable human blood cells. Transfusion. 2007;47:1042–9. doi: 10.1111/j.1537-2995.2007.01233.x. [DOI] [PubMed] [Google Scholar]
  • 27.Néron S, Pelletier A, Chevrier MC, Monier G, Lemieux R, Darveau A. Induction of LFA-1 independent human B cell proliferation and differentiation by binding of CD40 with its ligand. Immunol Invest. 1996;25:79–89. doi: 10.3109/08820139609059292. [DOI] [PubMed] [Google Scholar]
  • 28.Adderson EE, Shackelford PG, Quinn A, Carroll WL. Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide. J Immunol. 1991;147:1667–74. [PubMed] [Google Scholar]
  • 29.Giudicelli V, Chaume D, Lefranc MP. IMGT/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis. Nucleic Acids Res. 2004;32:W435–40. doi: 10.1093/nar/gkh412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94:1848–54. [PubMed] [Google Scholar]
  • 31.Huang SC, Glas AM, Pinchuk GV, Van Montfort EH, Rao SP, Jiang R, Milner EC. Human B cells accumulate immunoglobulin V gene somatic mutations in a cell contact-dependent manner in cultures supported by activated T cells but not in cultures supported by CD40 ligand. Clin Exp Immunol. 1999;116:441–8. doi: 10.1046/j.1365-2249.1999.00919.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Weller S, Braun MC, Tan BK, et al. Human blood IgM “memory” B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 2004;104:3647–54. doi: 10.1182/blood-2004-01-0346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Weller S, Faili A, Aoufouchi S, Gueranger Q, Braun M, Reynaud CA, Weill JC. Hypermutation in human B cells in vivo and in vitro. Ann NY Acad Sci. 2003;987:158–65. doi: 10.1111/j.1749-6632.2003.tb06044.x. [DOI] [PubMed] [Google Scholar]
  • 34.Weller S, Faili A, Garcia C, et al. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc Natl Acad Sci USA. 2001;98:1166–70. doi: 10.1073/pnas.98.3.1166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Tangye SG, Good KL. Human IgM+CD27+ B cells: memory B cells or “Memory” B cells? J Immunol. 2007;179:13–9. doi: 10.4049/jimmunol.179.1.13. [DOI] [PubMed] [Google Scholar]
  • 36.Horst A, Hunzelmann N, Arce S, et al. Detection and characterization of plasma cells in peripheral blood: correlation of IgE+ plasma cell frequency with IgE serum titre. Clin Exp Immunol. 2002;130:370–8. doi: 10.1046/j.1365-2249.2002.02025.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Medina F, Segundo C, Campos-Caro A, Gonzalez-Garcia I, Brieva JA. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood. 2002;99:2154–61. doi: 10.1182/blood.v99.6.2154. [DOI] [PubMed] [Google Scholar]
  • 38.Jung J, Choe J, Li L, Choi YS. Regulation of CD27 expression in the course of germinal center B cell differentiation: the pivotal role of IL-10. Eur J Immunol. 2000;30:2437–43. doi: 10.1002/1521-4141(2000)30:8<2437::AID-IMMU2437>3.0.CO;2-M. [DOI] [PubMed] [Google Scholar]
  • 39.Odendahl M, Mei H, Hoyer BF, et al. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood. 2005;105:1614–21. doi: 10.1182/blood-2004-07-2507. [DOI] [PubMed] [Google Scholar]
  • 40.van Laar JM, Melchers M, Teng YKO, et al. Sustained secretion of immunoglobulin by long-lived human tonsil plasma cells. Am J Pathol. 2007;171:917–27. doi: 10.2353/ajpath.2007.070005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Martin SW, Goodnow CC. Burst-enhancing role of the IgG membrane tail as a molecular determinant of memory. Nat Immunol. 2002;3:182–8. doi: 10.1038/ni752. [DOI] [PubMed] [Google Scholar]
  • 42.McHeyzer-Williams MG. B cells as effectors. Curr Opin Immunol. 2003;15:354–61. doi: 10.1016/s0952-7915(03)00046-3. [DOI] [PubMed] [Google Scholar]
  • 43.Lohning M, Richter A, Radbruch A. Cytokine memory of T helper lymphocytes. Adv Immunol. 2002;80:115–81. doi: 10.1016/s0065-2776(02)80014-1. [DOI] [PubMed] [Google Scholar]
  • 44.Lee BO, Haynes L, Eaton SM, Swain SL, Randall TD. The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. J Exp Med. 2002;196:693–704. doi: 10.1084/jem.20020845. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Koguchi Y, Thauland TJ, Slifka MK, Parker DC. Preformed CD40 ligand exists in secretory lysosomes in effector and memory CD4+ T cells and is quickly expressed on the cell surface in an antigen-specific manner. Blood. 2007;110:2520–7. doi: 10.1182/blood-2007-03-081299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Casamayor-Palleja M, Khan M, MacLennan IC. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T cell receptor complex. J Exp Med. 1995;181:1293–301. doi: 10.1084/jem.181.4.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Caccamo N, Battistini L, Bonneville M, et al. CXCR5 identifies a subset of Vgamma9Vdelta2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production. J Immunol. 2006;177:5290–5. doi: 10.4049/jimmunol.177.8.5290. [DOI] [PubMed] [Google Scholar]
  • 48.van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol. 2000;67:2–17. doi: 10.1002/jlb.67.1.2. [DOI] [PubMed] [Google Scholar]
  • 49.Lesley R, Kelly LM, Xu Y, Cyster JG. Naive CD4 T cells constitutively express CD40L and augment autoreactive B cell survival. Proc Natl Acad Sci USA. 2006;103:10717–22. doi: 10.1073/pnas.0601539103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Allen CD, Okada T, Tang HL, Cyster JG. Imaging of germinal center selection events during affinity maturation. Science. 2007;315:528–31. doi: 10.1126/science.1136736. [DOI] [PubMed] [Google Scholar]
  • 51.Shaffer AL, Lin KI, Kuo TC, et al. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity. 2002;17:51–62. doi: 10.1016/s1074-7613(02)00335-7. [DOI] [PubMed] [Google Scholar]
  • 52.Tourigny MR, Ursini-Siegel J, Lee H, et al. CDK inhibitor p18(INK4c) is required for the generation of functional plasma cells. Immunity. 2002;17:179–89. doi: 10.1016/s1074-7613(02)00364-3. [DOI] [PubMed] [Google Scholar]
  • 53.McHeyzer-Williams LJ, Malherbe LP, McHeyzer-Williams MG. Checkpoints in memory B-cell evolution. Immunol Rev. 2006;211:255–68. doi: 10.1111/j.0105-2896.2006.00397.x. [DOI] [PubMed] [Google Scholar]
  • 54.Lens SM, Tesselaar K, van Oers MH, van Lier RA. Control of lymphocyte function through CD27-CD70 interactions. Semin Immunol. 1998;10:491–9. doi: 10.1006/smim.1998.0154. [DOI] [PubMed] [Google Scholar]
  • 55.Borst J, Hendriks J, Xiao Y. CD27 and CD70 in T cell and B cell activation. Curr Opin Immunol. 2005;17:275–81. doi: 10.1016/j.coi.2005.04.004. [DOI] [PubMed] [Google Scholar]
  • 56.Agematsu K, Nagumo H, Oguchi Y, et al. Generation of plasma cells from peripheral blood memory B cells: synergistic effect of interleukin-10 and CD27/CD70 interaction. Blood. 1998;91:173–80. [PubMed] [Google Scholar]
  • 57.Arens R, Nolte MA, Tesselaar K, Heemskerk B, Reedquist KA, van Lier RA, van Oers MH. Signaling through CD70 regulates B cell activation and IgG production. J Immunol. 2004;173:3901–8. doi: 10.4049/jimmunol.173.6.3901. [DOI] [PubMed] [Google Scholar]
  • 58.Cabatingan MS, Schmidt MR, Sen R, Woodland RT. Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J Immunol. 2002;169:6795–805. doi: 10.4049/jimmunol.169.12.6795. [DOI] [PubMed] [Google Scholar]
  • 59.van Zelm MC, Szczepanski T, van der Burg M, van Dongen JJ. Replication history of B lymphocytes reveals homeostatic proliferation and extensive antigen-induced B cell expansion. J Exp Med. 2007;204:645–55. doi: 10.1084/jem.20060964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Agenes F, Rosado MM, Freitas AA. Peripheral B cell survival. Cell Mol Life Sci. 2000;57:1220–8. doi: 10.1007/PL00000761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Freitas AA, Rocha B. Population biology of lymphocytes: the flight for survival. Annu Rev Immunol. 2000;18:83–111. doi: 10.1146/annurev.immunol.18.1.83. [DOI] [PubMed] [Google Scholar]
  • 62.Agenes F, Freitas AA. Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J Exp Med. 1999;189:319–29. doi: 10.1084/jem.189.2.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Woodland RT, Schmidt MR. Homeostatic proliferation of B cells. Semin Immunol. 2005;17:209–17. doi: 10.1016/j.smim.2005.02.006. [DOI] [PubMed] [Google Scholar]
  • 64.van Zelm MC, van der Burg M, van Dongen JJ. Homeostatic and maturation-associated proliferation in the peripheral B-cell compartment. Cell Cycle. 2007;6:2890–5. doi: 10.4161/cc.6.23.4952. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES